Vertex Pharmaceuticals Inc / Ma

Assenagon Asset Management S.A. VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/9/2026

Shares

832,853

Value ($000)

377,582

Weight

0.6%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/9/2026	377,582	0.6%	832,853	12/31/2025
2025 Q3	10/7/2025	299,097	0.4%	763,703	9/30/2025
2025 Q2	7/11/2025	108,074	0.2%	242,754	6/30/2025
2025 Q1	4/15/2025	100,910	0.2%	208,140	3/31/2025
2024 Q4	1/14/2025	338,136	0.6%	839,672	12/31/2024
2024 Q3	10/23/2024	144,939	0.3%	311,643	9/30/2024
2024 Q2	7/18/2024	45,089	0.1%	96,195	6/30/2024
2024 Q1	4/24/2024	135,054	0.4%	323,088	3/31/2024
2023 Q4	1/17/2024	120,502	0.4%	296,153	12/31/2023
2023 Q3	11/6/2023	70,324	0.2%	202,231	9/30/2023
2023 Q2	7/25/2023	135,386	0.5%	384,718	6/30/2023
2023 Q1	4/18/2023	194,964	0.8%	618,796	3/31/2023
2022 Q4	1/12/2023	213,405	0.9%	738,987	12/31/2022
2022 Q3	10/27/2022	191,744	0.8%	662,235	9/30/2022
2022 Q2	7/27/2022	145,403	0.6%	515,998	6/30/2022
2022 Q1	4/25/2022	211,008	0.7%	808,554	3/31/2022
2021 Q4	2/1/2022	70,762	0.3%	322,231	12/31/2021
2021 Q3	10/19/2021	12,603	0.1%	69,479	9/30/2021
2021 Q2	7/15/2021	47,610	0.2%	236,128	6/30/2021
2021 Q1	4/26/2021	58,828	0.3%	273,759	3/31/2021
2020 Q4	2/1/2021	141,437	0.8%	598,446	12/31/2020
2020 Q3	10/7/2020	33,829	0.2%	124,316	9/30/2020
2020 Q2	7/21/2020	36,472	0.3%	125,630	6/30/2020
2020 Q1	4/17/2020	182,644	1.9%	767,571	3/31/2020
2019 Q4	1/17/2020	58,987	0.6%	269,408	12/31/2019